Compare companies
Sector
Report publication year
This is a small selection of the indicators assessed within the Framework. Use the drop-down options above to focus on a particular sector or publication year. Click on the company name to view the individual dashboard, or for a comprehensive insight download the latest full dataset. Presence of a dash (–) indicates there is no data related to this metric. Additional companies and financial years will be added as assessments become available.
| Name | Living wage accredited | Tax reporting (GRI 207) | Remuneration committee discretion (direction) | Director from workforce | Trade union relations (disclosure) | Worker consultation on top pay (disclosure) | 80%+ shareholder support on pay | CEO total pay (GBP) | CEO total pay change | CEO pay ratio (to median employee) | Gender pay (women % in top quartile) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AstraZeneca plc |  |
 |
— | |
|
|
|
14,728,000 | -12.61% | 153:1 | 43.60% |
| ConvaTec Group plc | |
|
— | |
|
|
|
5,059,000 | 18.64% | 87:1 | 47% |
| GSK plc | |
|
— | |
|
|
|
10,559,000 | -16.98% | 123:1 | 48.39% |
| Haleon plc | |
|
— | |
|
|
|
9,062,000 | 57.24% | 82:1 | 42% |
| Hikma Pharmaceuticals plc | |
|
— | |
|
|
|
2,798,840 | 129.81% | — | — |
| Smith & Nephew plc | |
|
— | |
|
|
|
6,113,113 | 68% | 110:1 | 36% |